Comparison

GSK 217043 eDiary vs Shared Investigator Platform

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head

Shared Investigator Platform

Streamline clinical trials

Free

🏥 Medical

★ 5.05 ratingsView app →

About

GSK 217043 eDiary

Features

Read full description

GSK eCOA App is intended for use in collecting patient reported outcomes relating to a clinical trial. Patients must be given accounts by a participating site in order to log in to the app.

About

Shared Investigator Platform

This mobile application allows clinical trial site users to manage their actions on the Shared Investigator Platform. It facilitates easy login, E-signing, reviewing pending actions, accepting study invitations, and managing study staff. Users can also access study documents, complete tasks, and receive important notifications.

Highlights

User-friendly interface
E-sign functionality
Biometric authentication
Review pending actions
Accept study invitations
Manage study staff
Access study documents

Features

Read full description

The Shared Investigator Platform (Cognizant SIP) Mobile App features a user friendly interface to navigate and manage your actions on the Shared Investigator Platform. With this app, site users can easily login and E-sign using their existing SIP credentials and enable biometric authentication to simplify the subsequent login and E-signature processes. This app offers an easy review of the pending actions, accept study invitations, View and generate FDA Form1572, view the study news, acknowledge safety notifications, add and manage study site staff, view study documents, complete Document Exchange tasks published by your sponsor organizations and receive push notifications of latest study news published and assigned tasks.

Screenshots

GSK 217043 eDiary4 screens

Shared Investigator Platform4 screens

Verdict

The call

The clearest difference is iOS requirement: GSK 217043 eDiary at 12.0 against Shared Investigator Platform's 15.6. On price, update cadence, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

GSK 217043 eDiary ships an update every 3 months, Shared Investigator Platform every 6 months. The most recent releases landed on November 7, 2026 and November 3, 2026 respectively.

Scorecard1 real difference · 9 level

GSK 217043 eDiary versus Shared Investigator Platform: the parameters behind the verdict, then further details
Parameter	GSK 217043 eDiary	Shared Investigator Platform
Price	Free	Free
Rating	—	5.0 (5 ratings) — better
Positive reviews	—	100.0% of reviews
Number of ratings	—	5 — better
Update frequency	Every 3 months — better	Every 6 months
Ads	No	No
In-app purchases	No	No
Monetization	—	Free
Devices	iPhone, iPad, iPod	iPhone, iPad, iPod
Requires iOS	12.0 — better	15.6
Further details — not scored
Size	57 MB	49 MB
Age rating	12+	17+
Developer	ERT, INC	Cognizant Technology Solutions

In-app purchases

None

GSK 217043 eDiary

No in-app purchases

None

Shared Investigator Platform

No in-app purchases

Questions

Is GSK 217043 eDiary free?

GSK 217043 eDiary is free to download, with no in-app purchases.

Is Shared Investigator Platform free?

Shared Investigator Platform is free to download, with no in-app purchases.

Do GSK 217043 eDiary or Shared Investigator Platform have ads?

Neither GSK 217043 eDiary nor Shared Investigator Platform shows ads.

Which is updated more often, GSK 217043 eDiary or Shared Investigator Platform?

GSK 217043 eDiary ships an update every 3 months, and Shared Investigator Platform every 6 months. Most recently, GSK 217043 eDiary was updated on November 7, 2026 and Shared Investigator Platform on November 3, 2026.